VitaNova Life Sciences Corp (VNOV) › Operating IncomeVitaNova Life Sciences Corp (VNOV) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$48.6K2019: -$71.8K2020: -$72.3K2021: -$52.1K2022: -$13.4K2023: -$24.2K2024: $205.6K2025: $1.21M$1.21M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$1.21M+487.6%2024$205.6K+948.8%2023-$24.2K-81.2%2022-$13.4K+74.3%2021-$52.1K+28.0%2020-$72.3K-0.7%2019-$71.8K-47.6%2018-$48.6K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share